Literature DB >> 22867891

Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.

Sheryl A Flanagan1, Kristin S Cooper, Sudha Mannava, Mikhail A Nikiforov, Donna S Shewach.   

Abstract

PURPOSE: To determine the effect of short hairpin ribonucleic acid (shRNA)-mediated suppression of thymidylate synthase (TS) on cytotoxicity and radiosensitization and the mechanism by which these events occur. METHODS AND MATERIALS: shRNA suppression of TS was compared with 5-fluoro-2'-deoxyuridine (FdUrd) inactivation of TS with or without ionizing radiation in HCT116 and HT29 colon cancer cells. Cytotoxicity and radiosensitization were measured by clonogenic assay. Cell cycle effects were measured by flow cytometry. The effects of FdUrd or shRNA suppression of TS on dNTP deoxynucleotide triphosphate imbalances and consequent nucleotide misincorporations into deoxyribonucleic acid (DNA) were analyzed by high-pressure liquid chromatography and as pSP189 plasmid mutations, respectively.
RESULTS: TS shRNA produced profound (≥ 90%) and prolonged (≥ 8 days) suppression of TS in HCT116 and HT29 cells, whereas FdUrd increased TS expression. TS shRNA also produced more specific and prolonged effects on dNTPs deoxynucleotide triphosphates compared with FdUrd. TS shRNA suppression allowed accumulation of cells in S-phase, although its effects were not as long-lasting as those of FdUrd. Both treatments resulted in phosphorylation of Chk1. TS shRNA alone was less cytotoxic than FdUrd but was equally effective as FdUrd in eliciting radiosensitization (radiation enhancement ratio: TS shRNA, 1.5-1.7; FdUrd, 1.4-1.6). TS shRNA and FdUrd produced a similar increase in the number and type of pSP189 mutations.
CONCLUSIONS: TS shRNA produced less cytotoxicity than FdUrd but was equally effective at radiosensitizing tumor cells. Thus, the inhibitory effect of FdUrd on TS alone is sufficient to elicit radiosensitization with FdUrd, but it only partially explains FdUrd-mediated cytotoxicity and cell cycle inhibition. The increase in DNA mismatches after TS shRNA or FdUrd supports a causal and sufficient role for the depletion of dTTP thymidine triphosphate and consequent DNA mismatches underlying radiosensitization. Importantly, shRNA suppression of TS avoids FP-mediated TS elevation and its negative prognostic role. These studies support the further exploration of TS suppression as a novel radiosensitizing strategy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867891      PMCID: PMC3494755          DOI: 10.1016/j.ijrobp.2012.06.050

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells.

Authors:  M M Seidman; K Dixon; A Razzaque; R J Zagursky; M L Berman
Journal:  Gene       Date:  1985       Impact factor: 3.688

Review 2.  Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.

Authors:  B Van Triest; G J Peters
Journal:  Oncology       Date:  1999-10       Impact factor: 2.935

3.  Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.

Authors:  M A Davis; H Y Tang; J Maybaum; T S Lawrence
Journal:  Int J Radiat Biol       Date:  1995-05       Impact factor: 2.694

4.  Mean inactivation dose: a useful concept for intercomparison of human cell survival curves.

Authors:  B Fertil; H Dertinger; A Courdi; E P Malaise
Journal:  Radiat Res       Date:  1984-07       Impact factor: 2.841

5.  The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.

Authors:  C J McGinn; E M Miller; M J Lindstrom; K A Kunugi; P G Johnston; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-11-15       Impact factor: 7.038

6.  Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds.

Authors:  John C Schmitz; Tian-min Chen; Edward Chu
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

7.  Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

Authors:  E Chu; D M Koeller; P G Johnston; S Zinn; C J Allegra
Journal:  Mol Pharmacol       Date:  1993-04       Impact factor: 4.436

Review 8.  Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.

Authors:  Sanjay Popat; Athena Matakidou; Richard S Houlston
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

9.  Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.

Authors:  H A Ingraham; B Y Tseng; M Goulian
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

Review 10.  Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.

Authors:  Tyvin A Rich; Robert C Shepard; Stephen T Mosley
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  1 in total

1.  Drug metabolism and homologous recombination repair in radiosensitization with gemcitabine.

Authors:  Michael M Im; Sheryl A Flanagan; Jeffrey J Ackroyd; Donna S Shewach
Journal:  Radiat Res       Date:  2015-01-07       Impact factor: 2.841

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.